Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01289392
Other study ID # CEP 0352/09
Secondary ID
Status Completed
Phase N/A
First received January 31, 2011
Last updated April 25, 2013
Start date October 2010

Study information

Verified date March 2013
Source Associação Fundo de Incentivo à Pesquisa
Contact n/a
Is FDA regulated No
Health authority Brazil: Comissão Nacional de Ética em Pesquisa
Study type Interventional

Clinical Trial Summary

Introduction: It is unclear whether exercise training with or without Continuous Positive Airway Pressure (CPAP) and Oral Appliance (OA) is more effective in reducing symptoms of Obstructive Sleep Apnea (OSA) than treatment solely with CPAP or OA.

Objective: In patients with moderate OSA, the investigators will evaluate the effect on the subjective and objective measures of sleep, quality of life and mood of different forms of treatment: exercise training of 4 months; exercise training of 4 months associated with CPAP and OA; treatment with CPAP and treatment with OA.

Material and Methods: Sixty male patients (25-65 years, sedentary lifestyle, Body Mass Index (BMI) < 35kg/m2, Apnea-Hypopnea Index (AHI) between 15-30/h, Epworth sleepiness scale > 9) will be divided into three groups: CPAP+exercise group (CE; n=20), OA+exercise group (AE; n=20), and Exercise training group (E; n=20). The patients in groups CE and AE will complete two months of treatment with CPAP or OA to examine the separate effects of these devices. As the patients of the E group did not use the CPAP but will undergo four months of exercise training. After this initial step, patients in CE and AE groups will undergo four months of exercise training associated with CPAP or OA. The investigators will evaluate the subjective sleep parameters (sleep disorders questionnaire, the Epworth Sleepiness Scale, sleep diaries) and objective (polysomnography), Short Form Health Survey (SF-36), Questionnaire Profile of Mood States (POMS) and anthropometric measurements (neck circumference and body composition), the incremental exercise test (ergospirometry) and the one Repetition Maximum test (1RM).


Recruitment information / eligibility

Status Completed
Enrollment 25
Est. completion date
Est. primary completion date January 2013
Accepts healthy volunteers No
Gender Male
Age group 25 Years to 65 Years
Eligibility Inclusion Criteria:

- Male subjects aged between 25 and 65 years old

- Sedentary according to the criteria of Godin and Shephard (1985) and / or ACSM (2000)

- Epworth Sleepiness Scale over score of nine

- Normal range of laboratory tests [blood count, cholesterol, High-density lipoprotein (HDL), triglycerides, fasting glucose, creatinine, Thyroid-stimulating hormone (TSH)]

- Lung function test (spirometry), chest X-ray (for smokers and former smokers) electrocardiogram (rest and stress) and ENT examination without significant changes

Exclusion Criteria:

- Presence of clinical diseases (chronic obstructive pulmonary disease, asthma, interstitial lung diseases, neuromuscular diseases, heart failure, thyroid disease, rheumatologic and psychiatric) and other sleep disorders

- Presence of anatomical obstructive upper airway, tonsil grade III and IV septal deviation and grade III (severe) that may affect the outcome of CPAP

- Loss of posterior dental support to undermine the retention of oral appliance

- Active periodontal disease, compared Dental crown / dental root less than or equal to 1 (c / r = 1), need for primary dental care (cavities, root canal treatment or retreatment, dentures, ie outlying), open bite

- Protrusive displacement less than five millimeters

- Limited mouth opening (would prevent the forming of the dental arches)

- Alcoholism

- Uuse of sleep-inducing medications

- Habits or occupations that lead to sleep deprivation or alteration of the sleep-wake cycle

- Inability to perform physical exercise, regular history sports activities

- Intolerance to Continuous Positive Airway Pressure (CPAP)

- Obesity grade II (moderate) and III (severe)

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment


Intervention

Device:
Continuous Positive Airway Pressure (CPAP)
Previously determinated airway pressure: used for two months unassociated with physical exercise and used for four months associated with physical exercise
Oral Appliance (OA)
Anterior mandibular repositioner: used for two months unassociated with physical exercise and used for four months associated with physical exercise
Behavioral:
Physical Exercise
aerobic and resistance Physical exercise, three times a week, for four months

Locations

Country Name City State
Brazil Instituto do Sono/Associação Fundo de Incentivo a Psicofarmacologia São Paulo SP

Sponsors (1)

Lead Sponsor Collaborator
Associação Fundo de Incentivo à Pesquisa

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Objective Sleep Parameters Polysomnographic date of sleep stages percentages, sleep efficiency, arousals, apnea-hypopnea index, oxyhemoglobin saturation 6 months after the basal evaluation No
Primary Sleep Apnea Number of events per hour of sleep 6 months Yes
Secondary Inflammatory Markers Blood samples to test: tumor necrosis factor-alpha (TNF-alpha), C-reactive protein (CRP), Interleukin-6 and Interleukin-8 6 months after the basal evaluation No
See also
  Status Clinical Trial Phase
Recruiting NCT05857384 - Bioavailability, Bioequivalence and Tolerability of IHL-42X Compared to the Reference Drugs Phase 1
Recruiting NCT04547543 - Follow-up of Apneic Patients by Visio-consultation N/A
Recruiting NCT05371509 - Novel Myofunctional Water Bottle to Reduce OSA and Snoring Study N/A
Completed NCT02515357 - Mediterranean Diet/Lifestyle Intervention in Obstructive Sleep Apnea N/A
Completed NCT05582070 - Effect on Sleep of Surgical Treatment of Severe Nasal Obstruction N/A
Active, not recruiting NCT03189173 - Combined Upper-airway and Breathing Control Therapies for Obstructive Sleep Apnea Phase 2
Completed NCT04084899 - The Effect of CPAP on Lung Hyperinflation in Patients With OSA
Completed NCT03032029 - Registry on the Treatment of Central and Complex Sleep-Disordered Breathing With Adaptive Servo-Ventilation
Recruiting NCT04028011 - Clinical Evaluation of a Wearable Technology for the Diagnosis of Sleep Apnoea
Recruiting NCT06047353 - Community Health Advocates for Motivating PAP Use in Our Neighborhoods. N/A
Completed NCT05253963 - Acute Effect of CPAP on Weight in Patients With Obstructive Sleep Apnea N/A
Recruiting NCT06029959 - Stroke and CPAP Outcome Study 3 N/A
Recruiting NCT06150352 - Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
Completed NCT03589417 - Postural Stability, Balance and Fall Risk in Patients With Obstructive Sleep Apnea
Recruiting NCT04335994 - ENhancing Outcomes in Cognitive Impairment Through Use of Home Sleep ApNea Testing N/A
Withdrawn NCT04063436 - Evaluation of a New Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea N/A
Recruiting NCT05385302 - Sociological Determinants of Positive Airway Pressure Adherence in OSA Patients
Recruiting NCT04572269 - Metabolomics of Obstructive Sleep Apnea
Not yet recruiting NCT06467682 - 12-week Tele-exercise Program in Patients With OSA N/A
Withdrawn NCT04011358 - Retinal Vein Occlusion and Obstructive Sleep Apnea: A Case Control Study N/A